These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10509848

  • 21. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Sezgin Akçay Bİ, Güney E, Bozkurt KT, Unlü C, Akçali G.
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
    [Abstract] [Full Text] [Related]

  • 22. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Dec; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 23. Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures.
    Solish AM, DeLucca PT, Cassel DA, Kolodny AH, Hustad CM, Skobieranda F.
    J Glaucoma; 2004 Apr; 13(2):149-57. PubMed ID: 15097262
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
    Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I.
    Clin Ther; 1998 Apr; 20(3):454-66. PubMed ID: 9663361
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Simmons ST, Alphagan/Trusopt Study Group.
    Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E, Tipping R, Vogel R.
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.
    Shedden A, Adamsons IA, Getson AJ, Laurence JK, Lines CR, Hewitt DJ, Ho TW.
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1757-64. PubMed ID: 20437244
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A, Paczka JA, Jiménez-Román J, Hartleben C.
    BMC Ophthalmol; 2014 Dec 19; 14():161. PubMed ID: 25527295
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.
    Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC.
    Eye (Lond); 2000 Feb 19; 14 ( Pt 1)():73-7. PubMed ID: 10755105
    [Abstract] [Full Text] [Related]

  • 37. Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.
    Kałuzny JJ, Szaflik J, Czechowicz-Janicka K, Kałuzny J, Orzalkiewicz A, Zaleska A, Krajewska M, Stewart JA, Leech JN, Stewart WC.
    Acta Ophthalmol Scand; 2003 Aug 19; 81(4):349-54. PubMed ID: 12859261
    [Abstract] [Full Text] [Related]

  • 38. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM, Stewart RH, Stewart WC, Jia G, Smugar SS, Galet VA.
    Curr Med Res Opin; 2008 Aug 19; 24(8):2403-12. PubMed ID: 18627642
    [Abstract] [Full Text] [Related]

  • 39. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.
    Strahlman E, Tipping R, Vogel R.
    Am J Ophthalmol; 1996 Aug 19; 122(2):183-94. PubMed ID: 8694086
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.